Departments of Molecular Medicine and Haematology, National Health Laboratory Service and University of the Witwatersrand, Johannesburg, South Africa.
J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):460-6. doi: 10.1097/QAI.0b013e31820bb06a.
HIV infection has been associated with an increased risk of non-Hodgkin lymphoma, particularly in the first world. Despite the high burden of HIV infection in sub-Saharan regions, published data on HIV and malignancies are sparse from these areas.
We recently published data on lymphomas diagnosed from January 2004 to December 2006, at a single center in Johannesburg, to serve as a baseline for long-term comparison during the period of highly active antiretroviral therapy rollout. We report a retrospective analysis of the follow-up data collected from January 2007 to December 2009 at the Johannesburg academic hospital complex (Gauteng, South Africa).
There were 2225 new diagnoses of lymphoproliferative disorders made during 2007-2009 as compared with 1897 cases diagnosed during 2004-2006. A significant increase in both high-grade B-cell lymphomas and Hodgkin lymphoma was documented during 2007-2009. This was associated with a statistically significant increase in HIV prevalence in those tested (from 44.3% in 2004-2006 to 62.0% in 2007-2009). HIV-positive patients presented at a statistically significantly younger median age and showed a relative overrepresentation of females when compared with HIV-negative patients. HIV-positive patients were diagnosed at later stages of HIV infection when compared with patients in the first world.
The pattern of lymphoma subtypes and the demographics of the patients diagnosed have altered in association with significantly increased HIV prevalence. These changes have important public health implications. In particular, scale-up and earlier access to highly active antiretroviral therapy is essential with continued monitoring as access to therapy improves.
HIV 感染与非霍奇金淋巴瘤风险增加相关,尤其在第一世界。尽管 HIV 在撒哈拉以南地区的感染负担很高,但来自这些地区的关于 HIV 和恶性肿瘤的已发表数据却很少。
我们最近公布了 2004 年 1 月至 2006 年 12 月在约翰内斯堡单一中心诊断的淋巴瘤数据,作为在高效抗逆转录病毒治疗推出期间进行长期比较的基线。我们报告了 2007 年 1 月至 2009 年 12 月在约翰内斯堡学术医院综合体(南非豪登省)收集的随访数据的回顾性分析。
与 2004-2006 年诊断的 1897 例相比,2007-2009 年期间诊断出 2225 例新的淋巴增生性疾病。高等级 B 细胞淋巴瘤和霍奇金淋巴瘤的数量均显著增加。这与检测到的 HIV 流行率呈统计学显著增加相关(从 2004-2006 年的 44.3%增加到 2007-2009 年的 62.0%)。HIV 阳性患者的中位年龄明显较年轻,与 HIV 阴性患者相比,女性的相对比例也更高。与第一世界的患者相比,HIV 阳性患者在 HIV 感染的晚期被诊断出。
与 HIV 流行率显著增加相关,淋巴瘤亚型的模式和诊断患者的人口统计学特征发生了变化。这些变化具有重要的公共卫生意义。特别是,随着治疗机会的增加,需要扩大规模并尽早获得高效抗逆转录病毒治疗,同时还需要继续监测。